← Back to Search

Coaching and Weight Loss for patients with dyspnea for Lung Disease

N/A
Waitlist Available
Led By Roberto P Benzo
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a lifestyle intervention to see if it can help obese people with chronic lung disease and breathlessness.

Eligible Conditions
  • Lung Disease
  • Chronic Obstructive Pulmonary Disease
  • Emphysema
  • CPFE Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Breathlessness
Secondary study objectives
Body Mass Index using InBody 770 Scale
Daily Physical Activity
Daily Sedentary Time
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multicomponent Intervention for weight lossExperimental Treatment1 Intervention
12-week intervention that consists of Weight Watcher on-line program, Garmin Fitness Tracker, blue-tooth scale, and telephonic health coaching.
Group II: Wait-list ControlActive Control1 Intervention
The participant will receive usual care for 12 weeks and then will compassionately be offered the active intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coaching and Weight Loss for patients with dyspnea
2019
N/A
~30

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,350 Previous Clinical Trials
3,060,646 Total Patients Enrolled
Roberto P BenzoPrincipal InvestigatorMayo Clinic
8 Previous Clinical Trials
592 Total Patients Enrolled
~5 spots leftby Dec 2025